Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NKE +9.5%, UEC +2.1%, BB +1.3%
Other news:
- APRN +133.7% (to be acquired by Wonder Group for $13/share in cash)
- CTRN +9.7% (Fund 1 Investments discloses 9.98% active stake)
- NAAS +5.8% (NaaS Technology and ZSY reach strategic cooperation to promote financial innovation and develop new energy industry)
- CCCS +5.6% (Bain Capital weighing deal for CCCS according to Bloomberg)
- OPK +5.3% (secures BARDA contract to develop antibodies against viral infectious disease threats)
- NBTX +5.2% (presents data from Phase 1 study of NBTXR3)
- CCO +4.9% (settles with SEC will pay $26.1 mln fine)
- PTCT +4.8% (announces further strategic prioritization; also 25% workforce reduction)
- MDGL +3.7% (prices $500 mln public offering)
- FTI +2.6% (awarded a "significant" flexible pipe contract by Petrobras)
- QGEN +1.8% (extends AI capabilities of its NGS interpretation software)
- GETY +1.4% (stock offering by selling shareholders)
- GPCR +1.4% (Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update)
- LAC +1% (announces details for completion of separation)
- KSS +1% (to move to S&P Small Cap 600 from S&P MidCap 400)
Analyst comments:
- FUSN +6.1% (initiated with an Outperform at Oppenheimer)
- TRMB +2.1% (upgraded to Outperform from Mkt Perform at Raymond James)
- TXRH +1.5% (upgraded to Buy from Neutral at Northcoast)
- INGR +1.3% (initiated with an Outperform at Oppenheimer)
- IONS +1.3% (initiated with a Strong Buy at Raymond James)
- QSR +1.2% (upgraded to Buy from Hold at Loop Capital)